NCT07147049View on ClinicalTrials.gov

Evaluate the Safety and Efficacy of HL-1186 Tablet for Moderate to Severe Acute Pain After Surgery

PHASE2RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Moderate to Severe Acute Postoperative Pain
Interventions
DRUG

HL-1186

HL-1186 tablet for oral administration.

DRUG

HL-1186 placebo

HL-1186 placebo tablet for oral administration.

Trial Locations (1)

Unknown

RECRUITING

Sichuan Provincial People's Hospital, Chengdu

All Listed Sponsors
lead

Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.

INDUSTRY

NCT07147049 - Evaluate the Safety and Efficacy of HL-1186 Tablet for Moderate to Severe Acute Pain After Surgery | Biotech Hunter | Biotech Hunter